We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
As work continues on remedying a host of concerning issues at Emergent BioSolutions’ Bayview, Md., facility, Health Canada has reported that the 1.5 million AstraZeneca (AZ) doses it received from the site were up to par for safety and quality. Read More
The Biden administration has decided to begin sharing its AstraZeneca (AZ) vaccine supply with the rest of the world while the shots go unused in the U.S., as the government also begins delivering supplies of raw materials needed to make the vaccine in COVID-ridden India. Read More
Using automated software analysis and the company’s PlexPrep liquid handling system, 480 to 1,920 patient samples can be processed in an 8-hour shift, the company said. Read More
The FDA on Friday amended its Emergency Use Authorization (EUA) for the Johnson & Johnson COVID-19 vaccine to reflect the risk of rare blood clots and said vaccinations could resume immediately, based on recommendations by a Centers for Disease Control and Prevention (CDC) advisory committee. Read More
The EU has made clear that it will set its sights on obtaining additional doses of Pfizer/BioNTech’s and Moderna’s mRNA-based COVID-19 vaccines, opting to pass on pursuing more doses of AstraZeneca (AZ)’s adenoviral-vector vaccine. Read More
As global criminals step up efforts to exploit the pandemic, Pfizer is combating the sale of counterfeit versions of its COVID-19 vaccines in Mexico and Poland. Read More